University College London Hospitals NHS Foundation Trust was seeking the court's authority to administer a treatment known as PRN100 to a patient who was suffering from sporadic CJD. Permission was granted.
The P was suffering from sporadic CJD (a life threatening condition where the P may survive only 6 months) and he and his family wanted to him to undergo treatment with PRN100, a novel and experimental treatment. The court had to weigh up the risks and benefits of such treatment.
The court agreed that the P could undergo the treatment as it was plainly in his best interests.
Read the full text of the judgment on Bailii
Case summaries on every Court of Protection case & other relevant decisions with links to the full judgment where available.
Sign up for our free email alert
We do not share your details with any third parties and you can unsubscribe at any time
Useful books from Bath Publishing